跳至主要内容
临床试验/JPRN-UMIN000022275
JPRN-UMIN000022275尚未招募未知

Basic research aiming for clinical application of 5-aminolevulinic acid in musculoskeletal sarcomas - Basic research aiming for clinical application of 5-ALA in musculoskeletal sarcomas

Saitama Medical University International Medical Center0 个研究点目标入组 20 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Having difficulty in taking medication 2. Still having severe adverse effects of previous treatment for sarcomas 3. Having un-controlled infection 4. Severe complications, such as malignant hypertension, severe congestive heart failure, myocardial infarction within 3 months, terminal cirrhosis, un-controlled diabetes, severe pulmonary fibrosis, active interstitial pneumonia 5. Allergy to porphyrin-related substances 6. Porphyria 7. Other active cancer including hematologic malignancy

研究者

相似试验